Virginia’s psilocybin decriminalization bill has been defeated by a Senate committee after the top GOP lawmaker reversed his support

About a week after Colorado activists tabled revised versions of 2022 ballot initiatives to legalize psilocybin and create ‘healing centers’ in the state, a second campaign has submitted its own competing proposal to legalize psychedelics. .

On Friday, activists from Decriminalize Nature Boulder County filed the new one-page initiative. This would allow adults 21 and older to possess, grow, give and deliver psilocybin, psilocyn, ibogaine, mescaline and DMT.

Additionally, the measure states that it would be legal to provide psychedelic services for counseling, therapy and harm reduction and spiritual purposes with or without payment. However, it would not be legal to sell any of the psychedelics.

The campaign is led by activists Nicole Foerster and Melanie Rodgers, a supporter of Denver’s 2019 psilocybin decriminalization initiative, who also called for successful decriminalization action in Washington, DC.

“Without decriminalization and the safety it allows affected communities to organize more effectively, regulatory models will make it difficult for the most disadvantaged groups of our population to continue to access the natural medicines they use safely to heal”, Foerster noted in a press release. “To address this issue, we advocate a simple change to existing laws regarding these controlled substances.”

New deposit is a sign of a split between Colorado advocates who share the goal of ending the criminalization of psychedelics and ensuring access, but who apparently disagree on the regulatory approach.

The separate, recently revised initiatives filed by the well-funded New Approach national PAC and backed by people like philanthropist David Bronner of Dr. Bronner’s soap company are much deeper and contain key differences from the simple legalization proposal. of adult use which has now been introduced.

Under the revised measures, titled the Natural Medicine Health Act, there would be a two-tier regulatory model, where only psilocybin would be legalized and regulated for therapeutic use until June 2026, after which regulators could expand the change in policy to include other psychedelics listed in the proposal such as ibogaine, DMT and mescaline that are not derived from peyote.

The decision to add additional psychedelics to the program would be made by the Department of Regulatory Agencies in consultation with a Natural Medicine Advisory Board that would be established. The council would consist of 15 members, including people with experience of psychedelic medicine in a scientific and religious context.

There would be no possession limits for entheogenic substances, unlike the initial measures that were filed by the campaign last month.

This latest filing comes more than two years after Denver became the first city in the United States to decriminalize psilocybin mushrooms. Kevin Matthews, who served as campaign manager for that local push, is now a lead petitioner for the statewide ballot effort. Various activists involved in the 2019 campaign have expressed interest in building on the reform.

Initiatives must always be assigned an official voting title and state summary before they are approved to begin collecting signatures. Larger measurements are program to receive a review and comment hearing on February 3, while the new initiative filed on Friday is scheduled to be heard on February 11.

If approved by state officials, activists will need to collect 124,632 valid signatures from registered voters to gain access to the ballot.

Colorado’s ballot initiatives seek to accomplish something similar to what California activists are actively pursuing. California advocates are collecting signatures for a ballot initiative to legalize psilocybin mushrooms in the state.

Meanwhile, in Colorado, Sen. Joann Ginal (D) and Rep. Alex Valdez (D) introduced a modest bill this month to create a herbal medicine policy review committee. year-long plants that would study “the use of plant-based medicines to support mental health,” according to a abstract. The election campaign is not affiliated with this legislative effort.

“The Policy Review Committee will report its findings and policy recommendations to the House of Representatives Public and Behavioral Health and Human Services Committee and the Senate Health and Human Services Committee, or to any successor commission; the governor; and the Department of Social Services,” he says.

Meanwhile, legislative efforts to enact psychedelic reform are also underway in other states across the country.

For example, a bill to decriminalize a wide range of psychedelic substances in Virginia was considered by a House of Delegates panel on Monday, only to be pushed back until 2023. A separate Senate proposal to decriminalize psilocybin alone was rejected by a key committee on Monday. .

In Oregon, where voters approved a landmark 2020 initiative to legalize the therapeutic psilocybin program, as well as another to broadly decriminalize currently illegal drugs, lawmakers last week introduced a bill to to promote equity in the program.

Two Oklahoma Republican lawmakers recently introduced bills intended to promote research into the therapeutic potential of psilocybin, and one of the measures would further decriminalize low-level possession of the psychedelic.

A Utah GOP lawmaker also introduced a bill this month that would establish a task force to study and make recommendations on the therapeutic potential of psychedelic drugs and possible regulations for their legal use.

In Kansas, a lawmaker also recently introduced a bill to legalize the possession and low-level cultivation of psilocybin mushrooms.

A Republican lawmaker in Missouri introduced a bill this month to give residents with serious illnesses legal access to a range of psychedelic drugs like psilocybin, ibogaine and LSD through an expanded version of the law. existing state on the right to try.

California Senator Scott Wiener (D) told Marijuana Moment in a recent interview that his bill to legalize possession of psychedelics has a 50/50 chance of reaching the governor’s office this year. He has already authorized the entire Senate and two Assembly committees during the first half of the two-year session.

In Michigan, two state senators introduced a bill in September to legalize the possession, cultivation, and delivery of various plant and mushroom-derived psychedelics like psilocybin and mescaline.

Washington state lawmakers also introduced legislation this month that would legalize what the bill calls “supported psilocybin experiments” by adults 21 and older.

In Vermont, a broad coalition of lawmakers representing nearly a third of the House introduced a bill to decriminalize drug possession.

New Hampshire lawmakers have introduced measures to decriminalize psilocybin and all drugs.

Last year, Connecticut’s governor signed a law that includes language requiring the state to conduct a study into the therapeutic potential of psilocybin mushrooms.

At the congressional level, bipartisan lawmakers sent a letter to the Drug Enforcement Administration (DEA) this month urging the agency to allow terminally ill patients to use psilocybin as an experimental treatment without fear of federal prosecution.

Schumer provides update on federal marijuana legalization and banking in meeting with equity advocates

Photo elements courtesy of carlosemmaskype and Apollo.

Marijuana Moment is made possible by the support of readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon Pledge.

Comments are closed.